Fortis Healthcare Considers Supreme Court Appeal Over Daiichi Sankyo Ruling

Fortis Healthcare is contemplating a potential appeal to the Supreme Court following a significant ruling by the Delhi High Court in the ongoing Daiichi Sankyo arbitration case. The High Court's decision mandates a forensic audit of Fortis’ financial transactions, marking a critical development that could result in substantial contingent liabilities for the healthcare provider.

Delhi High Court's Forensic Audit Directive

The Delhi High Court's judgment, delivered by Justice Subramonium Prasad, spans 213 pages and orders a thorough forensic audit of Fortis' transactions. This audit covers the period when the Singh brothers controlled the company up until the acquisition by IHH Healthcare. The court's decision arises from allegations that these transactions may have violated judicial orders and potentially obstructed the execution of a prior decree in favor of Daiichi Sankyo.

Justice Prasad's ruling explicitly states that any party found to have breached court orders could face legal consequences. The judgment allows for the reversal of transactions and the imposition of direct compensation liabilities to Daiichi Sankyo on those found culpable.

Potential Supreme Court Appeal

In light of these developments, Fortis Healthcare is reportedly reviewing the judgment with a view towards possibly challenging the decision in the Supreme Court. Legal experts have indicated that the court's ruling opens the door for a wide array of remedies, including financial restitution from any parties involved in facilitating transactions that contravened existing judicial orders.

Fortis Healthcare, now under new management, cannot claim ignorance of the alleged misdeeds of its previous leadership, according to the High Court. This sets a precedent that holds current management accountable for past management's actions, a situation that Fortis may seek to address in a higher court.

Legal Implications and Industry Reactions

The High Court's directive has significant implications for Fortis Healthcare and its stakeholders. The ruling underscores the judiciary's firm stance on ensuring compliance with court orders and maintaining the integrity of legal processes. The decision has prompted discussions within the industry about the broader impacts on corporate governance and accountability.

Senior advocates Arvind Nigam and Giriraj Subramanium represented Daiichi Sankyo in the proceedings, emphasizing the need for accountability and adherence to legal mandates. The case continues to attract attention as it unfolds, with potential repercussions for Fortis' operational and financial strategies.

As Fortis Healthcare considers its next steps, the industry watches closely to see whether the company will pursue a Supreme Court appeal, which could further extend the legal battle over the Daiichi Sankyo arbitration.